www.analystratings.com/articles/...y-rating-on-synlogic-sybx/
MK 86 Mio. USD / Cash 138 Mio. Kohle soll bis 2021 reichen:
Corporate
Synlogic ended the third quarter of 2019 with $138.7 million in cash, cash equivalents and short- and long-term investments and expects that this will fund Company operations through 2021 under its current plan.
The Company will continue to explore additional strategic opportunities to maximize the potential of its Synthetic Biotic platform.
investor.synlogictx.com/news-releases/...linical-programs-and
MK 86 Mio. USD / Cash 138 Mio. Kohle soll bis 2021 reichen:
Corporate
Synlogic ended the third quarter of 2019 with $138.7 million in cash, cash equivalents and short- and long-term investments and expects that this will fund Company operations through 2021 under its current plan.
The Company will continue to explore additional strategic opportunities to maximize the potential of its Synthetic Biotic platform.
investor.synlogictx.com/news-releases/...linical-programs-and